Myomo Inc. with ticker code (MYO) now have 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 16 and 11.25 with a mean TP of 13.81. Given that the stocks previous close was at 10.6 this would indicate that there is a potential upside of 30.3%. The day 50 moving average is 8.65 and the 200 day moving average is 5.63. The company has a market capitalisation of $53m. Find out more information at: http://www.myomo.com
Myomo, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient’s weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors. Myomo was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.